Dengue Hemorrhagic Fever in an adult traveler returning to Japan

Internal Medicine

Volumn 51, Issue 13, 2012, Pages 1779-1782

  Goto, Koji ^a   Hatakeyama, Shuji ^a   Okamoto, Koh ^a   Kitazawa, Takatoshi ^a,b   Abe, Katsutoshi ^a   Moriya, Kyoji ^a   Koike, Kazuhiko ^a   Yotsuyanagi, Hiroshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antibody dependent enhancement; Dengue hemorrhagic fever (DHF); Dengue shock syndrome (DSS); Plasma leakage phase

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; IMMUNOGLOBULIN G ANTIBODY; INFUSION FLUID;

ADULT; ANOREXIA; ARTICLE; ASCITES; BLOOD CLOTTING DISORDER; CASE REPORT; CONSCIOUSNESS DISORDER; DENGUE; DENGUE VIRUS 2; DIARRHEA; EMPORIATRICS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPISTAXIS; FEVER; HEMATOCRIT; HUMAN; HYPOALBUMINEMIA; JAPAN; LEUKOPENIA; MACULOPAPULAR RASH; MALAISE; MALE; NAUSEA; PETECHIA; PLEURA EFFUSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY INFECTION; THORAX RADIOGRAPHY; THROMBOCYTOPENIA;

COINFECTION; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; HUMANS; JAPAN; MALE; MIDDLE AGED; MYANMAR; TRAVEL;

EID: 84863527154     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.7397     Document Type: Article

References (22)

1. Wilder-Smith A, Schwartz E. Dengue in travelers. N Engl J Med 353: 924-932, 2005.
2. World Health Organization. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. 2nd ed. World Health Organization, Geneva, 1997.
3. Gibbons RV, Vaughn DW. Dengue: an escalating problem. BMJ 324: 1563-1566, 2002.
4. Gubler DJ. The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res 33: 330-342, 2002.
5. Guzmán MG, Kourí G. Dengue: an update. Lancet Infect Dis 2: 33-42, 2002.
6. Stephenson JR. Understanding dengue pathogenesis: implications for vaccine design. Bull World Health Organ 83: 308-314, 2005.
7. Bernardo L, Izquierdo A, Prado I, et al. Primary and secondary infections of Macaca fascicularis monkeys with Asian and American genotypes of dengue virus 2. Clin Vaccine Immunol 15: 439-446, 2008.
8. Kochel TJ, Watts DM, Halstead SB, et al. Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever. Lancet 360: 310-312, 2002.
9. Deen J, Lum L, Martinez E, Tan LH. Clinical management and delivery of clinical services. In: Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. New ed. World Health Organization, Geneva, 2009: 25-58.
10. Jelinek T, Mqhlberger N, Harms G, et al. Epidemiology and clinical features of imported dengue fever in Europe: sentinel surveillance data from TropNetEurop. Clin Infect Dis 35: 1047-1052, 2002.
11. Hills SL, Piispanen JP, Humphreys JL, Foley PN. A focal, rapidlycontrolled outbreak of dengue fever in two suburbs in Townsville, north Queensland, 2001. Commun Dis Intell 26: 596-600, 2002.
12. Hotta S. Dengue epidemics in Japan, 1942-1945. J Trop Med Hyg 56: 83, 1953.
13. Okuno Y, Harada T, Ogawa M, Okamoto Y, Maeda K. A case of dengue hemorrhagic fever in a Japanese child. Microbiol Immunol 33: 649-655, 1989.
14. Malavige GN, Fernando S, Fernando DJ, Seneviratne SL. Dengue viral infections. Postgrad Med J 80: 588-601, 2004.
15. Halstead SB. Dengue. Lancet 370: 1644-1652, 2007.
16. Bandyopadhyay S, Lum LC, Kroeger A. Classifying dengue: a review of the difficulties in using the WHO case classification for dengue haemorrhagic fever. Trop Med Int Health 11: 1238-1255, 2006.
17. Halstead SB, O'Rourke EJ. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med 146: 201-217, 1977.
18. Halstead SB. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis 140: 527-533, 1979.
19. Mongkolsapaya J, Dejnirattisai W, Xu XN, et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 9: 921-927, 2003.
20. Fink J, Gu F, Vasudevan SG. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever. Rev Med Virol 16: 263-275, 2006.
21. Kuno G, Gómez I, Gubler DJ. An ELISA procedure for the diagnosis of dengue infections. J Virol Methods 33: 101-113, 1991.
22. Sierra B, García G, Pérez AB, et al. Long-term memory cellular immune response to dengue virus after a natural primary infection. Int J Infect Dis 6: 125-128, 2002.